Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08CA061931-01A2
Application #
2102807
Study Section
Cancer Research Manpower and Education Review Committee (CRME)
Project Start
1996-06-06
Project End
2001-05-31
Budget Start
1996-06-06
Budget End
1997-05-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Illinois Urbana-Champaign
Department
Pathology
Type
Schools of Medicine
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
Deszo, Eric L; Brake, Danett K; Kelley, Keith W et al. (2004) IL-4-dependent CD86 expression requires JAK/STAT6 activation and is negatively regulated by PKCdelta. Cell Signal 16:271-80
O'Connor, Jason C; Freund, Gregory G (2003) Vanadate and rapamycin synergistically enhance insulin-stimulated glucose uptake. Metabolism 52:666-74
Godbout, Jonathan P; Pesavento, James; Hartman, Matthew E et al. (2002) Methylglyoxal enhances cisplatin-induced cytotoxicity by activating protein kinase Cdelta. J Biol Chem 277:2554-61
Hartman, M E; Villela-Bach, M; Chen, J et al. (2001) Frap-dependent serine phosphorylation of IRS-1 inhibits IRS-1 tyrosine phosphorylation. Biochem Biophys Res Commun 280:776-81
Deszo, E L; Brake, D K; Cengel, K A et al. (2001) CD45 negatively regulates monocytic cell differentiation by inhibiting phorbol 12-myristate 13-acetate-dependent activation and tyrosine phosphorylation of protein kinase Cdelta. J Biol Chem 276:10212-7
Godbout, J P; Cengel, K A; Cheng, S L et al. (1999) Insulin activates caspase-3 by a phosphatidylinositol 3'-kinase-dependent pathway. Cell Signal 11:15-23
Cengel, K A; Freund, G G (1999) JAK1-dependent phosphorylation of insulin receptor substrate-1 (IRS-1) is inhibited by IRS-1 serine phosphorylation. J Biol Chem 274:27969-74
Cengel, K A; Kason, R E; Freund, G G (1998) Phosphatidylinositol 3'-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase. Biochem J 335 ( Pt 2):397-404